GlobalData on MSN5d
FDA grants 510(k) clearance to Zimmer’s new revision knee implant componentThe US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component ...
New bone cement formulations designed for prosthesis fixation in arthroplasty and joint reconstruction procedures ...
The Terminator actor teamed up with Zimmer Biomet to raise awareness about osteoarthritis, which affects more than 25 million ...
On Thursday, 13 March 2025, Zimmer Biomet Holdings Inc. (NYSE ... The product side of the equation, the implant is now something like 20% to 25% of the DRG, whereas ten, twenty years ago it ...
March 10, 2025 /PRNewswire/ -- Zimmer Biomet Holdings ... benefit from a shorter surgical time compared to the cemented implant. The Oxford Partial Knee Is not indicated for use in the lateral ...
Zacks Investment Research on MSN1d
Zimmer Biomet Focuses on Innovation Amid Growing CompetitionZimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting ...
On Thursday, 13 March 2025, Zimmer Biomet Holdings Inc. (NYSE ... The product side of the equation, the implant is now something like 20% to 25% of the DRG, whereas ten, twenty years ago it was north ...
Stryker continues to enjoy extensive financial flexibility, even as it has issued more debt to finance the purchase of some larger acquisitions. At the end of 2024, the firm's net debt/EBITDA was 1.9 ...
Credit: Anciens Huang / Shutterstock. The US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet’s new revision knee implant component, Persona Revision SoluTion Femur, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback